Increasing findings support that upregulated LT-α expression plays a vital role in immune diseases and that blocking LT-α might be a potential treatment for diseases such as rheumatoid arthritis and GVHD [14, 15, 19]. This evidence concerns the gene LTA and graft versus host disease.